Overview

A Study to Evaluate the Effect of a Single Oral Dose of ZX-7101A on the QTc Interval in Healthy Subjects

Status:
COMPLETED
Trial end date:
2023-12-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effect of a single oral dose of ZX-7101A on the QTc interval in healthy subjects.
Phase:
PHASE1
Details
Lead Sponsor:
Nanjing Zenshine Pharmaceuticals